DEVELOPMENT AND VALIDATION OF A HEALTH POLICY SIMULATION MODEL FOR TYPE 1 DIABETES

Grant number: 1028335 | Funding period: 2012 - 2015

Completed

Abstract

This proposal brings together an international multi-disciplinary team to develop and validate a health economic computer simulation model for type 1 diabetes and its complications. It examines the impact of diabetes on costs as well as quality of life. Outcomes generated by the model will inform health policy decisions regarding allocation of resources for people with type 1 diabetes such as cost-effectiveness analysis of new treatments and technologies.

Related publications (7)

Scholarly works icon

Development of a life expectancy table for individuals with type 1 diabetes

An Tran-Duy, Josh Knight, Philip M Clarke, Ann-Marie Svensson, Bjorn Eliasson, Andrew J Palmer

2021-07-26

AIMS/HYPOTHESIS: Tables reporting life expectancies by common risk factors are available for individuals with type 2 diabetes; how..

Scholarly works icon

A Patient-Level Model to Estimate Lifetime Health Outcomes of Patients With Type 1 Diabetes

An Tran-Duy, Josh Knight, Andrew J Palmer, Dennis Petrie, Tom WC Lung, William H Herman, Bjorn Eliasson, Ann-Marie Svensson, Philip M Clarke

2020-08-01

OBJECTIVE: To develop a patient-level simulation model for predicting lifetime health outcomes of patients with type 1 diabetes an..

Scholarly works icon

Recent trends in life expectancy for people with type 1 diabetes in Sweden

Dennis Petrie, Tom WC Lung, Aidin Rawshani, Andrew J Palmer, Ann-Marie Svensson, Bjorn Eliasson, Philip Clarke

2016-06-01

AIMS/HYPOTHESIS: People with type 1 diabetes have reduced life expectancy (LE) compared with the general population. Our aim is to..

Scholarly works icon

Expenditures and Prices of Antihyperglycemic Medications in the United States: 2002-2013

Xinyang Hua, Natalie Carvalho, Michelle Tew, Elbert S Huang, William H Herman, Philip Clarke

2016-04-05

Scholarly works icon

A Meta-Analysis of the Relative Risk of Mortality for Type 1 Diabetes Patients Compared to the General Population: Exploring Temporal Changes in Relative Mortality

Tom WC Lung, Alison J Hayes, William H Herman, Lei Si, Andrew J Palmer, Philip M Clarke

2014-11-26

AIMS: Type 1 diabetes has been associated with an elevated relative risk (RR) of mortality compared to the general population. To ..

Scholarly works icon

Severe Hypoglycemia and Mortality After Cardiovascular Events for Type 1 Diabetic Patients in Sweden

Tom WC Lung, Dennis Petrie, William H Herman, Andrew J Palmer, Ann-Marie Svensson, Bjorn Eliasson, Philip M Clarke

2014-11-01

OBJECTIVE: To examine whether previous severe hypoglycemic events were associated with the risk of all-cause mortality after major..

Scholarly works icon

Simulating Lifetime Outcomes Associated with Complications for People with Type 1 Diabetes

Tom WC Lung, Philip M Clarke, Alison J Hayes, Richard J Stevens, Andrew Farmer

2013-01-01

OBJECTIVES: The aim of this study was to develop a discrete-time simulation model for people with type 1 diabetes mellitus, to est..

University of Melbourne Researchers